Biological Drug API Manufacturing Services Market Report 2023-2033

Biological Drug API Manufacturing Services Market Report 2023-2033



The Biological Drug API Manufacturing Services Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Dynamic Role of APIs in Combatting Various Diseases

APIs (Active Pharmaceutical Ingredients) play a crucial role in various medical treatments, including cancer, cardiovascular disease, diabetes, infectious diseases, pain relief, and respiratory conditions. They significantly aid in the development of medications targeting bacterial and viral infections, contributing to advancements in therapeutic solutions.

Infectious diseases, a leading cause of global mortality, profoundly impact public health and economic progress. The emergence of drug-resistant strains in diseases like malaria and tuberculosis, along with insecticide-resistant organisms, has led to the necessity for more intricate medical interventions. These complexities have enduring financial and health implications for patients.

Given the adverse effects of these illnesses on worldwide health, the escalating resistance to antimicrobials, and the diminishing availability of effective antibiotics, innovative businesses are compelled to focus on discovering and producing new therapeutic medications to address these challenges.

Strategic Partnerships and Collaborations

Partnerships and collaborations within the pharmaceutical industry offer CMOs producing biological drug APIs substantial growth prospects. Creating strategic partnerships with pharmaceutical companies, universities, and research centres can encourage resource sharing, knowledge sharing, and innovation.

CMOs can help partners accelerate their drug development timelines by bringing their process development, optimisation, and scale-up expertise to early-stage collaborations. In addition, access to proprietary platforms, cutting-edge technologies, and intellectual property is made possible through strategic partnerships, which improve the CMO's capabilities and broaden its range of services.

Additionally, by forming consortia or alliances with several pharmaceutical companies, CMOs can broaden their clientele, become less reliant on a single partner, and build a network for collaborative research and development. In the field of biological drug manufacturing, collaborative approaches enable the sharing of resources, knowledge, and risk in a way that benefits both parties and promotes innovation and expansion.

What Questions Should You Ask before Buying a Market Research Report?
  • How is the biological drug API manufacturing services market evolving?
  • What is driving and restraining the biological drug API manufacturing services market?
  • How will each biological drug API manufacturing services submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each biological drug API manufacturing services submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading biological drug API manufacturing services markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the biological drug API manufacturing services projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of
biological drug API manufacturing services projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the biological drug API manufacturing services market?
  • Where is the biological drug API manufacturing services market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the biological drug API manufacturing services market today, and over the next 10 years:
  • Our 261-page report provides 89 tables, 135 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the biological drug API manufacturing services market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Manufacturing Type
  • Outsourced
  • In-house
Application
  • Vaccines
  • mABs
  • Insulin Analogues
  • Interferon Therapies
  • Human Growth Hormones
  • Others
Expression Platform
  • Mammalian Cell Cultures
  • Microbial Fermentations
  • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America
  • U.S.
  • Canada
Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South East Asia
  • Rest of Asia Pacific
Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
MEA
  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Biological Drug API Manufacturing Services Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report
  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Cytovance Biologics
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Piramal Pharma Solutions
  • Samsung Biologics
  • Thermo Fisher Scientific Inc.
Overall world revenue for Biological Drug API Manufacturing Services Market, 2023 to 2033 in terms of value the market will surpass US$8,000 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biological Drug API Manufacturing Services Market, 2023 to 2033 report help you?

In summary, our 260+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for Biological Drug API Manufacturing Services Market 2023 to 2033, with forecasts for manufacturing type, application and expression platform, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 22 key national markets – See forecasts for the Biological Drug API Manufacturing Services Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Biological Drug API Manufacturing Services Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Biological Drug API Manufacturing Services Market 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..

The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.


1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Biological Drug API Manufacturing Services Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Market Driving Factors
3.3.1 Biological Patent Expirations to Fuel Market Growth
3.3.2 Outsourcing as a Driver for Market Growth
3.3.3 Growing Investments in Orphan Drugs
3.3.4 Single Use Technology will Become Essential Over the Next Decade
3.4 Market Restraining Factors
3.4.1 Manufacturing APIs for Biologics to Restrain Market Growth
3.4.2 Pricing Pressure to Impede Market Growth
3.4.3 Regulatory Scenarios to Restrain Market Growth
3.4.4 Excessive Production is Projected to Impede Market Growth
3.4.5 API Production is a Challenging Task
3.5 Market Opportunities
3.5.1 Advancements in Bioprocessing Techniques
3.5.2 Customisation and Flexibility in Manufacturing
3.5.3 Strategic Partnerships and Collaborations
3.5.4 Emerging Economies to Offer Lucrative Growth Opportunities
3.6 SWOT Analysis
3.6.1 Strengths
3.6.2 Weaknesses
3.6.3 Opportunities
3.6.4 Threats
3.7 Industry analysis – PEST Analysis
3.7.1 Political
3.7.2 Economical
3.7.3 Social
3.7.4 Technological
3.8 Porter’s Five Forces Analysis
3.8.1 Bargaining Power of Suppliers is Low
3.8.2 Bargaining Power of Buyers is Medium
3.8.3 Competitive Rivalry is High Due to Presence of Established Firms
3.8.4 Threat of Substitutes is Medium
3.8.5 Threat of New Entrants is Low Owing to Huge Associated Costs
3.9 COVID-19 Impact Analysis
4 Biological Drug API Manufacturing Services Market Analysis by Manufacturing Type
4.1 Key Findings
4.2 Manufacturing Type Segment: Market Attractiveness Index
4.3 Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
4.4 Outsourced
4.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 In-house
4.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)
5 Biological Drug API Manufacturing Services Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
5.4 Vaccines
5.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 mABs
5.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Insulin Analogues
5.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Interferon Therapies
5.7.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Human Growth Hormones
5.8.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Others
5.9.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.9.2 Market Share by Region, 2023 & 2033 (%)
6 Biological Drug API Manufacturing Services Market Analysis by Expression Platform
6.1 Key Findings
6.2 Expression Platform Segment: Market Attractiveness Index
6.3 Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
6.4 Mammalian Cell Cultures
6.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Microbial Fermentations
6.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Others
6.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.6.2 Market Share by Region, 2023 & 2033 (%)
7 Biological Drug API Manufacturing Services Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Biological Drug API Manufacturing Services Market Analysis
8.1 Key Findings
8.2 North America Biological Drug API Manufacturing Services Market Attractiveness Index
8.3 North America Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
8.4 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
8.5 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
8.6 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
8.7 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
8.8 U.S. Biological Drug API Manufacturing Services Market Analysis
8.9 Canada Biological Drug API Manufacturing Services Market Analysis
9 Europe Biological Drug API Manufacturing Services Market Analysis
9.1 Key Findings
9.2 Europe Biological Drug API Manufacturing Services Market Attractiveness Index
9.3 Europe Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
9.5 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
9.6 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
9.7 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
9.8 Germany Biological Drug API Manufacturing Services Market Analysis
9.9 UK Biological Drug API Manufacturing Services Market Analysis
9.10 France Biological Drug API Manufacturing Services Market Analysis
9.11 Italy Biological Drug API Manufacturing Services Market Analysis
9.12 Spain Biological Drug API Manufacturing Services Market Analysis
9.13 Russia Biological Drug API Manufacturing Services Market Analysis
9.14 Rest of Europe Biological Drug API Manufacturing Services Market Analysis
10 Asia Pacific Biological Drug API Manufacturing Services Market Analysis
10.1 Key Findings
10.2 Asia Pacific Biological Drug API Manufacturing Services Market Attractiveness Index
10.3 Asia Pacific Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
10.5 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
10.6 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
10.7 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
10.8 Japan Biological Drug API Manufacturing Services Market Analysis
10.9 China Biological Drug API Manufacturing Services Market Analysis
10.10 India Biological Drug API Manufacturing Services Market Analysis
10.11 Australia Biological Drug API Manufacturing Services Market Analysis
10.12 South Korea Biological Drug API Manufacturing Services Market Analysis
10.13 South East Asia Biological Drug API Manufacturing Services Market Analysis
10.14 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Analysis
11 Latin America Biological Drug API Manufacturing Services Market Analysis
11.1 Key Findings
11.2 Latin America Biological Drug API Manufacturing Services Market Attractiveness Index
11.3 Latin America Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
11.5 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
11.6 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
11.7 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
11.8 Brazil Biological Drug API Manufacturing Services Market Analysis
11.9 Mexico Biological Drug API Manufacturing Services Market Analysis
11.10 Rest of Latin America Biological Drug API Manufacturing Services Market Analysis
12 MEA Biological Drug API Manufacturing Services Market Analysis
12.1 Key Findings
12.2 MEA Biological Drug API Manufacturing Services Market Attractiveness Index
12.3 MEA Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
12.5 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
12.6 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
12.7 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
12.8 GCC Biological Drug API Manufacturing Services Market Analysis
12.9 South Africa Biological Drug API Manufacturing Services Market Analysis
12.10 Rest of MEA Biological Drug API Manufacturing Services Market Analysis
13 Company Profiles
13.1 AbbVie Inc.
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.4 Service Benchmarking
13.1.5 Strategic Outlook
13.2 Lonza
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.4 Service Benchmarking
13.2.5 Strategic Outlook
13.3 Boehringer Ingelheim International GmbH
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.4 Service Benchmarking
13.3.5 Strategic Outlook
13.4 Catalent, Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.4 Service Benchmarking
13.4.5 Strategic Outlook
13.5 Piramal Pharma Solutions
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Service Benchmarking
13.5.4 Strategic Outlook
13.6 Cytovance Biologics
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Service Benchmarking
13.6.4 Strategic Outlook
13.7 FUJIFILM Diosynth Biotechnologies
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Service Benchmarking
13.7.4 Strategic Outlook
13.8 Thermo Fisher Scientific Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.4 Service Benchmarking
13.8.5 Strategic Outlook
13.9 Samsung Biologics
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Service Benchmarking
13.9.4 Strategic Outlook
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings